Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Cash on Hand 2010-2025 | UTHR

United Therapeutics cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • United Therapeutics cash on hand for the quarter ending March 31, 2025 was $3.321B, a 22.66% increase year-over-year.
  • United Therapeutics cash on hand for 2024 was $3.267B, a 9.11% increase from 2023.
  • United Therapeutics cash on hand for 2023 was $2.994B, a 5.47% increase from 2022.
  • United Therapeutics cash on hand for 2022 was $2.839B, a 47.03% increase from 2021.
  
United Therapeutics Annual Cash on Hand
(Millions of US $)
2024 $3,267
2023 $2,994
2022 $2,839
2021 $1,931
2020 $1,835
2019 $1,486
2018 $1,416
2017 $927
2016 $1,051
2015 $954
2014 $696
2013 $694
2012 $479
2011 $403
2010 $627
2009 $229
United Therapeutics Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $3,321
2024-12-31 $3,267
2024-09-30 $3,327
2024-06-30 $2,972
2024-03-31 $2,708
2023-12-31 $2,994
2023-09-30 $2,876
2023-06-30 $2,679
2023-03-31 $2,863
2022-12-31 $2,839
2022-09-30 $2,616
2022-06-30 $2,255
2022-03-31 $2,268
2021-12-31 $1,931
2021-09-30 $2,000
2021-06-30 $1,968
2021-03-31 $1,731
2020-12-31 $1,835
2020-09-30 $1,581
2020-06-30 $1,561
2020-03-31 $1,545
2019-12-31 $1,486
2019-09-30 $1,570
2019-06-30 $1,786
2019-03-31 $1,605
2018-12-31 $1,416
2018-09-30 $1,238
2018-06-30 $1,213
2018-03-31 $1,257
2017-12-31 $927
2017-09-30 $1,211
2017-06-30 $1,115
2017-03-31 $1,156
2016-12-31 $1,051
2016-09-30 $1,033
2016-06-30 $945
2016-03-31 $975
2015-12-31 $954
2015-09-30 $922
2015-06-30 $440
2015-03-31 $657
2014-12-31 $696
2014-09-30 $768
2014-06-30 $568
2014-03-31 $760
2013-12-31 $694
2013-09-30 $717
2013-06-30 $697
2013-03-31 $671
2012-12-31 $479
2012-09-30 $503
2012-06-30 $392
2012-03-31 $409
2011-12-31 $403
2011-09-30 $695
2011-06-30 $730
2011-03-31 $683
2010-12-31 $627
2010-09-30 $462
2010-06-30 $379
2010-03-31 $293
2009-12-31 $229
2009-09-30 $235
2009-06-30 $220
2009-03-31 $186
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.773B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.040B 31.90
Zoetis (ZTS) United States $72.587B 27.08
Daiichi Sankyo, - (DSNKY) Japan $46.334B 23.57
Takeda Pharmaceutical (TAK) Japan $44.897B 8.93
Sandoz Group AG (SDZNY) Switzerland $20.596B 0.00
Summit Therapeutics (SMMT) United States $17.727B 0.00
Merck (MKKGY) Germany $16.659B 12.21
Shionogi (SGIOY) Japan $12.948B 0.00
Neurocrine Biosciences (NBIX) United States $11.977B 41.02
IPSEN (IPSEY) France $9.572B 0.00
Orion OYJ (ORINY) Finland $8.798B 23.79
Corcept Therapeutics (CORT) United States $7.962B 64.72
Stevanato Group S.p.A (STVN) Italy $7.274B 44.48
Madrigal Pharmaceuticals (MDGL) United States $6.460B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.341B 0.00
Grifols, S.A (GRFS) Spain $5.335B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.780B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.973B 10.41
Crinetics Pharmaceuticals (CRNX) United States $2.925B 0.00
Hypermarcas (HYPMY) Brazil $2.692B 17.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.382B 12.88
BioCryst Pharmaceuticals (BCRX) United States $2.143B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.073B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.854B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.671B 0.00
Indivior (INDV) United States $1.564B 6.63
Guardian Pharmacy Services (GRDN) United States $1.563B 0.00
Evotec AG (EVO) Germany $1.442B 0.00
Dyne Therapeutics (DYN) United States $1.345B 0.00
ARS Pharmaceuticals (SPRY) United States $1.336B 0.00
Ocular Therapeutix (OCUL) United States $1.150B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.107B 22.14
Harrow (HROW) United States $1.042B 0.00
Collegium Pharmaceutical (COLL) United States $0.971B 5.24
Ardelyx (ARDX) United States $0.928B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.872B 0.00
Enliven Therapeutics (ELVN) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.825B 0.00
Xeris Biopharma Holdings (XERS) United States $0.763B 0.00
Akebia Therapeutics (AKBA) United States $0.685B 0.00
AleAnna (ANNA) United States $0.666B 0.00
KalVista Pharmaceuticals (KALV) United States $0.593B 0.00
Elite Pharmaceuticals (ELTP) United States $0.578B 0.00
Xencor (XNCR) United States $0.574B 0.00
USANA Health Sciences (USNA) United States $0.564B 12.26
Bioventus (BVS) United States $0.558B 14.15
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Savara (SVRA) United States $0.531B 0.00
CytoDyn (CYDY) United States $0.486B 0.00
Relay Therapeutics (RLAY) United States $0.482B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.460B 0.00
Altimmune (ALT) United States $0.453B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.431B 0.00
Siga Technologies (SIGA) United States $0.428B 8.94
Tourmaline Bio (TRML) United States $0.425B 0.00
Verve Therapeutics (VERV) United States $0.413B 0.00
Organogenesis (ORGO) United States $0.391B 0.00
Oruka Therapeutics (ORKA) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.355B 9.58
Heron Therapeutics (HRTX) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.20
Aquestive Therapeutics (AQST) United States $0.236B 0.00
ProKidney (PROK) United States $0.236B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.205B 0.00
OmniAb (OABI) United States $0.193B 0.00
Nanobiotix S.A (NBTX) France $0.182B 0.00
Avita Medical (RCEL) United States $0.171B 0.00
Wellgistics Health (WGRX) United States $0.170B 0.00
Liminatus Pharma (LIMN) $0.168B 0.00
Journey Medical (DERM) United States $0.160B 0.00
4D Molecular Therapeutics (FDMT) United States $0.159B 0.00
Esperion Therapeutics (ESPR) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.142B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
Profound Medical (PROF) Canada $0.142B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Larimar Therapeutics (LRMR) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.123B 0.00
Lyell Immunopharma (LYEL) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Lexeo Therapeutics (LXEO) United States $0.108B 0.00
Achieve Life Sciences (ACHV) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.098B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.088B 14.43
Dominari Holdings (DOMH) United States $0.087B 0.00
Fractyl Health (GUTS) United States $0.083B 0.00
Galectin Therapeutics (GALT) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.070B 52.33
Context Therapeutics (CNTX) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Surrozen (SRZN) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Karyopharm Therapeutics (KPTI) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Avalo Therapeutics (AVTX) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
FibroGen (FGEN) United States $0.031B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Lipocine (LPCN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Relmada Therapeutics (RLMD) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.83
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00